Utilizing and Integrating Data from China to Mutually
Support Global and Local Applications
James Cai, M.D., Vice President, R&D and Business
Development, AstraZeneca Pharmaceuticals, China

Country and Site Selection for Global Clinical Trials
Fidela Ll. Moreno, M.D., Executive Director, Global Development
Operations, Asia and Latin America, Amgen Inc.

Recent Regulatory Changes in India
Chandrashekhar Potkar, M.D., Director, Clinical Research,
Pfi zer Ltd. (India)

Optimizing Return on Investment (ROI) of Multinational
and Domestic Clinical Trials in China
Min Irwin, M.D., Ph.D., Medical Director of BSP China, Bayer
HealthCare Company Ltd.

Roles and Functioning of Institutional and Independent
Ethics Committees in India
Y.K. Gupta, Head, Dept. of Pharmacology; Coordinator, Zonal
Pharmacovigilance Centre, All India Institute of Medical Sciences

Safety Reporting in India Clinical Research Environment
Kamala Rai, M.D., Research Director, MSD Pharmaceuticals Pvt
Ltd; Medical Director, Merck (India)

Accelerate Oncology Clinical Development in Asia
Michael Shi, Director and Biomarker Project Leader, Exploratory
Oncology Development, Novartis Oncology

Are You Ready for an FDA Inspection?
Cherif Benattia, M.D., Vice President, Pharmacovigilance &
Public Health, Vertex Pharmaceuticals

The Strategic Planning Behind the Clinical Site Allocation
in Emerging Economies: An Industry-Wide View
Fabio Thiers, M.D., M.Sc., Ph.D., Research Associate, MIT Center
for Biomedical Innovation, MIT